Letter to Jeffrey S. Aronin, Chairman and Chief Executive Officer of Marathon Pharmaceuticals, LLC - Information Request on Pricing Plan for Emflaza (Deflazacort)
Letter
Date: Feb. 13, 2017
Location: Washington, DC
Issues: Health and Health Care Drugs